Purple Biotech Ltd. (PPBT) income statement
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech Ltd. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -124.0%
Financial strength
- Current ratio
- 1.27
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 112.4%
Valuation
- P/E ratio
- 0.0
- Price to sales
- –
- Price to book
- 0.16
- Dividend yield
- –
See a number that looks wrong?